mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |